INTRODUCTION: Cancer care involves addressing patient emotion. When patients express negative emotions, empathic opportunities emerge. When oncologists respond with a continuer statement, which is one that offers empathy and allows patients to continue expressing emotions, rather than with a terminator statement, which is one that discourages disclosure, patients have less anxiety and depression and report greater satisfaction and adherence to therapy. We studied whether oncologist traits were associated with empathic opportunities and empathic responses. PATIENTS AND METHODS: We audio-recorded 398 clinic conversations between 51 oncologists and 270 patients with advanced cancer; oncologists also completed surveys. Conversations were coded for the presence of empathic opportunities and oncologist responses. Analyses examined the relationship with oncologists' demographics, self-reported confidence, outcome expectancies, and comfort to address social versus technical aspects of care. RESULTS: In 398 conversations, 37% contained at least one empathic opportunity; the range was 0 to 10, and the total empathic opportunities was 292. When they occurred, oncologists responded with continuers 22% of the time. Oncologist sex was related to the number of empathic opportunities; female patients seen by female oncologists had the most empathic opportunities (P = .03). Younger oncologists (P = .02) and those who rated their orientation as more socioemotional than technical (P = .03) were more likely to respond with empathic statements. CONCLUSION: Oncologists encountered few empathic opportunities and responded with empathic statements infrequently. Empathic responses were more prevalent among younger oncologists and among those who were self-rated as socioemotional. To reduce patient anxiety and increase patient satisfaction and adherence, oncologists may need training to encourage patients to express emotions and to respond empathically to patients' emotions.
INTRODUCTION:Cancer care involves addressing patient emotion. When patients express negative emotions, empathic opportunities emerge. When oncologists respond with a continuer statement, which is one that offers empathy and allows patients to continue expressing emotions, rather than with a terminator statement, which is one that discourages disclosure, patients have less anxiety and depression and report greater satisfaction and adherence to therapy. We studied whether oncologist traits were associated with empathic opportunities and empathic responses. PATIENTS AND METHODS: We audio-recorded 398 clinic conversations between 51 oncologists and 270 patients with advanced cancer; oncologists also completed surveys. Conversations were coded for the presence of empathic opportunities and oncologist responses. Analyses examined the relationship with oncologists' demographics, self-reported confidence, outcome expectancies, and comfort to address social versus technical aspects of care. RESULTS: In 398 conversations, 37% contained at least one empathic opportunity; the range was 0 to 10, and the total empathic opportunities was 292. When they occurred, oncologists responded with continuers 22% of the time. Oncologist sex was related to the number of empathic opportunities; female patients seen by female oncologists had the most empathic opportunities (P = .03). Younger oncologists (P = .02) and those who rated their orientation as more socioemotional than technical (P = .03) were more likely to respond with empathic statements. CONCLUSION: Oncologists encountered few empathic opportunities and responded with empathic statements infrequently. Empathic responses were more prevalent among younger oncologists and among those who were self-rated as socioemotional. To reduce patientanxiety and increase patient satisfaction and adherence, oncologists may need training to encourage patients to express emotions and to respond empathically to patients' emotions.
Authors: James A Tulsky; Robert M Arnold; Stewart C Alexander; Maren K Olsen; Amy S Jeffreys; Keri L Rodriguez; Celette Sugg Skinner; David Farrell; Amy P Abernethy; Kathryn I Pollak Journal: Ann Intern Med Date: 2011-11-01 Impact factor: 25.391
Authors: Deepika Mohan; Stewart C Alexander; Sarah K Garrigues; Robert M Arnold; Amber E Barnato Journal: J Palliat Med Date: 2010-08 Impact factor: 2.947
Authors: Daneng Li; Ghassan K Abou-Alfa; Aaron D Viny; Meredith Cammarata; Ali Shamseddine; Ashwaq Al-Olayan; Hibah Osman; Ali Haydar; Ghassan Kanazi; Mohamed Naghy; Eileen M O'Reilly; Andrew S Epstein Journal: J Gastrointest Oncol Date: 2015-10
Authors: Anthony L Back; Robert M Arnold; Walter F Baile; James A Tulsky; Gwyn E Barley; Roy D Pea; Kelly A Fryer-Edwards Journal: J Clin Oncol Date: 2009-01-26 Impact factor: 44.544
Authors: Stewart C Alexander; Susan Ladwig; Sally A Norton; David Gramling; J Kelly Davis; Maureen Metzger; Jane DeLuca; Robert Gramling Journal: J Palliat Med Date: 2014-03-03 Impact factor: 2.947
Authors: Yael Schenker; Mary Amanda Dew; Charles F Reynolds; Robert M Arnold; Greer A Tiver; Amber E Barnato Journal: Palliat Support Care Date: 2014-02-13